Scientists identify group of genes shared between COVID-19 and diabetic kidney disease

Scientists have identified five hub genes that might be associated with severe coronavirus disease 2019 (COVID-19) outcomes in patients with diabetic kidney disease. The study is currently available on the bioRxiv* preprint server.

Study: Discovering hub genes involved in the pathophysiological impact of COVID-19 on diabetes kidney disease by differential gene expression and interactome analysis. Image Credit: 3DJustincase/Shutterstock
Study: Discovering hub genes involved in the pathophysiological impact of COVID-19 on diabetes kidney disease by differential gene expression and interactome analysis. Image Credit: 3DJustincase/Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Hub genes are those genes that exhibit many interactions with other genes and, thus, play important roles in regulating vital biological processes.

Background

Diabetes is a chronic endocrine disease that increases the risk of severe COVID-19. Evidence indicates that hyperinflammation is the primary causative factor of immunological complications during the clinical course of COVID-19. However, it is still uncertain how diabetes may increase the disease risk.

Diabetic kidney disease, also known as diabetic nephropathy, is a chronic kidney complication caused by hyperglycemia. About 30-40% of diabetic patients live with this health condition, and about 50% eventually develop end-stage kidney disease that requires dialysis or kidney transplantation.

Recent evidence has highlighted that patients with both diabetic kidney disease and COVID-19 develop multiple pathophysiological mechanisms between the lung and kidney. Patients with end-stage kidney disease also exhibit a higher risk of COVID-19-related mortality.

In the current study, scientists have conducted transcriptomics and network analysis to identify critical genes shared by the pathways affected by COVID-19 and diabetic kidney disease.

Study design

The scientists conducted bioinformatics analysis of transcriptomic data obtained from patients with diabetic kidney disease to identify predictive hub genes associated with COVID-19-related diabetic kidney complications. 

They characterized the genes that were differentially expressed in both disease conditions. Furthermore, they conducted a functional enrichment analysis of differentially expressed genes in the diabetic kidney disease dataset.

To identify the hub genes, they performed a protein-protein interaction network and topological analysis. Finally, they determined the co-expression modules of the identified hub genes and assessed their tissue-specific regulation.

Important observations

A total of 995 differentially expressed genes were characterized in the diabetic kidney disease dataset. Of these genes, 42 were connected to the COVID-19-related pathways and showed an upregulated expression profile.

A particular group of upregulated differentially expressed genes was connected to the complement and coagulation systems, which are known to associate with the pathophysiological mechanisms of COVID-19. As mentioned by the scientists, the interplay between complement- and coagulation-related biomolecules could significantly worsen COVID-19 outcomes in patients with diabetic kidney disease.

Another group of upregulated differentially expressed genes showed strong associations with pro-inflammatory, cell activation, oxidative stress, cell adhesion, and apoptosis pathways. In addition, some upregulated genes were found to associate with pathogen recognition receptor pathways, which are the vital components of the innate immune system to fight against invading pathogens.

Overall, these observations indicate that the overactivation of the innate immune system and inflammatory pathways due to aberrant gene expressions may act in a negative synergistic manner to cause the worst COVID-19 outcomes in patients with diabetic kidney disease.

Hub genes

The protein-protein network analysis identified a particular set of five hub genes, including STAT1, IRF7, ISG15, MX1, and OAS1. Besides being associated with COVID-19- and diabetic kidney disease-related biological and metabolic pathways, the hub genes showed strong connections with heart disease, impaired angiogenesis, and metabolic diseases. 

The interactome analysis findings revealed that the hub genes are co-expressed with other genes involved in cardiovascular disease, virus immune response, and genetic regulation at the transcriptional and post-transcriptional levels.    

Tissue-specific expression profile analysis of hub genes revealed that ISG15, STAT1, and MX1 have a consistently upregulated expression profile in the immune cells of COVID-19 patients. In addition, MX1 and OAS1 exhibited a lower expression profile in healthy kidney tissues.

As mentioned by the scientists, persistent activation of immune cells in chronic kidney disease together with higher expression of ISG15, STAT1, and MX1 can lead to higher production of pro-inflammatory cytokines and subsequent worsening of COVID-19 outcomes.

Study significance

The study identifies five hub genes that may play crucial roles in worsening COVID-19 outcomes in patients with diabetic kidney disease. These genes are associated with innate immune and inflammatory systems.

These genes can serve as potential prognostic or therapeutic targets to facilitate the development of novel drugs against COVID-19.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 16 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2023, May 16). Scientists identify group of genes shared between COVID-19 and diabetic kidney disease. News-Medical. Retrieved on October 03, 2024 from https://www.news-medical.net/news/20221017/Scientists-identify-group-of-genes-shared-between-COVID-19-and-diabetic-kidney-disease.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "Scientists identify group of genes shared between COVID-19 and diabetic kidney disease". News-Medical. 03 October 2024. <https://www.news-medical.net/news/20221017/Scientists-identify-group-of-genes-shared-between-COVID-19-and-diabetic-kidney-disease.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "Scientists identify group of genes shared between COVID-19 and diabetic kidney disease". News-Medical. https://www.news-medical.net/news/20221017/Scientists-identify-group-of-genes-shared-between-COVID-19-and-diabetic-kidney-disease.aspx. (accessed October 03, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2023. Scientists identify group of genes shared between COVID-19 and diabetic kidney disease. News-Medical, viewed 03 October 2024, https://www.news-medical.net/news/20221017/Scientists-identify-group-of-genes-shared-between-COVID-19-and-diabetic-kidney-disease.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
"Not just a phase": Fussy eating is mainly influenced by genes and is a stable trait